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Context Merkel cell carcinoma is a rare skin tumour which can metastasise to regional lymph nodes and occasionally to 
distant organs. Merkel cell carcinoma metastasis to the pancreas has been rarely reported. Case report We describe the case 
of Merkel cell carcinoma metastasis to the pancreas and review the literature on this rare phenomenon. Conclusion Merkel 
cell carcinomas metastasis should be considered as a differential in patients who present with a pancreatic mass with a 
previous history of Merkel cell carcinomas. 
 
INTRODUCTION 
Merkel cell carcinomas is a rare skin tumour first 
described by Toker in 1972. The cells arise from the 
amine precursor uptake and decarboxylation cell 
system and, although originally thought to migrate 
from the neural crest, recent mammalian studies 
suggest they develop from epidermal cell lineage. 
They only represent a fraction of skin cell tumours 
with an incidence of 0.18-0.41/100,000 and UV 
light and fair skin are known risk factors [1]. Merkel 
cell carcinoma show a propensity for local spread 
and metastasis to regional lymph nodes and, 
although distant metastasis has been reported in 
multiple sites including intra-abdominal, thoracic, 
and the central nervous system [2, 3, 4], pancreatic 
metastasis is rare. We present a case of pancreatic 
metastasis of Merkel cell carcinoma and review the 
literature concentrating particularly on the pattern 
of presentation of this rare disease and the variety 
of surgical, adjuvant and neo-adjuvant treatments 
available. 
CASE REPORT 
A 62-year-old Caucasian woman from regional 
Australia presented to our hospital in 2013 for 
investigation of a pancreatic mass found on CT 
whilst being investigated by her general 
practitioner for epigastric pain, bloating and 
anorexia. The scan showed a large mid-body 
pancreatic mass with vascular involvement, thought 
to be most likely a primary pancreatic tumour, and 
she was referred to our unit for further treatment 
(Figure 1). Her tumour markers including CA 19.9 
were normal and after discussion in the multi-
disciplinary meeting she underwent a trans-hepatic 
percutaneous biopsy for this unresectable mass. 
Pathological examination of this tissue showed 
CD56 and CK20 positivity and two independent 
pathologists reported it to be most likely of Merkel 
cell carcinoma origin. 
In 2004, she presented to her general practitioner 
with a lesion on the dorsum of her right hand. A 
punch biopsy was reported as being consistent with 
a squamous cell carcinoma in-situ and this was 
confirmed after complete excision. Several months 
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later a 25x20 mm lesion at the same location was 
excised without pre-operative punch biopsy as it 
was thought to be either recurrent squamous cell 
carcinoma or an infection. This lesion showed small 
to medium round cells, a high nuclear-to-
cytoplasmic ratio with an area of vague trabeculae 
highly suggestive of Merkel cell carcinoma. This was 
confirmed on immunohistochemistry as it was 
positive for CD56, several keratin markers and 
CK20. 
In light of this new diagnosis, further imaging was 
organised which revealed ipsilateral axillary 
lymphadenopathy. FNA was inconclusive so a 
lymph node biopsy was taken, which was consistent 
with lymph node metastasis of Merkel cell 
carcinoma, similar to the lesion on the right hand. A 
level 3 axillary clearance, including excision of the 
clinically involved thoracodorsal artery and nerve, 
was undertaken. All nodes were pathologically 
involved and the patient was referred for 
oncological treatment. She completed a course of 
radiotherapy; however, chemotherapy had to be 
ceased as she was admitted to ICU with severe 
sepsis. She survived that episode and lived 
independently till she was referred to our 
department almost 9 years later. 
After the diagnosis of metastatic Merkel cell 
carcinoma she was discharged home and was due to 
be followed up by oncology with a view to 
discussing the possibilities of oncological treatment. 
However, she was admitted 6 weeks later to her 
local hospital with general deterioration. Given the 
poor prognosis, her decreased reserve from the 
prior round of chemotherapy associated sepsis and 
underlying Parkinson’s disease she opted to 
undergo no further treatment. She passed away 
soon after this admission. 
After an extensive literature search, only 8 cases of 
Merkel cell carcinoma metastasising to the pancreas 
were identified (Table 1), the present study has 
been added to the table to allow easy comparison. 
Each article was reviewed and relevant references 
in those papers requested and reviewed as well. 
DISCUSSION 
This is a rare case with only 8 cases previously 
described in the literature and the third of its kind 
diagnosed by FNA or biopsy [10, 12]. It is worth 
noting that immunosuppression increases the risk 
of developing Merkel cell carcinoma [12, 13] and in 
particular kidney transplant patients have a 15-fold 
higher incidence compared to the general 
population [13]. This may explain two cases 
described in the literature; one with previous 
history of chronic lymphocytic leukaemia [10] and 
another on immunosuppression drugs post kidney 
and pancreatic transplant who developed Merkel 
cell carcinoma metastasis in his transplanted 
pancreas. Regional lymph node biopsy, rather than 
direct biopsy of the pancreas, yielded the diagnosis 
in this case [11]. 
Although this rare case report shares some 
similarities from the described cases in the 
literature, there are some unique features such as 









Diagnosed Survival b Adjuvant/neo-adjuvant therapy 
Safadi, 1996 [5] 69 
(CLL) 
Olecranon 2 years Head Post mortem N/A 300 mg/day cyclophosphamide, 
2 mg/day vincristine and 
160 mg/day prednisone 
Bachmeyer, 2002 [6] 57 Eyelid 6 months Body Post resection 2 months Died before chemotherapy started 
Ouellette, 2004 [7] 64 Finger 4 years Head Post resection 1 year Post-operative radiotherapy 54Gy in 25 
fractions over 40 days. 
Adsay, 2004 [8] 64 N/A N/A N/A Post resection N/A N/A 
Bachmann, 2005 [9] 82 Eyebrow 2 years Tail Post resection Alive (at time 
of reporting) 
Pre-operative radiotherapy 
(for unknown abdominal mass) 
Dim, 2008 [10] 79 Upper 
extremity 
15 months Tail FNA N/A N/A 




5 months 80 mg doxorubicin and 
800 mg cyclophosphamide 
Bernstein, 2012 [12] 56 Thigh 6 months Tail FNA N/A Radiotherapy to primary site and 
2 cycles of cisplatin- and etoposide-
based chemotherapy followed by 48.6 
Gy in 1.8 Gy fractions to pancreatic bed 
followed by 2 more cycles of cisplatin 
and etoposide 
Present report 62 Hand 9 years Body Biopsy 2 months Radiotherapy to primary site 
a Latency period from time of original diagnosis to time of diagnosis of pancreatic metastasis 
b Survival after diagnosis of pancreatic lesion 
CLL: chronic lymphocytic leukaemia 
FNA- fine needle aspiration 
N/A: not available 
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this being only one of two cases found in the body of 
the pancreas and one with the longest latency 
period; however, in keeping with three of the cases, 
survival was in months once the diagnosis was 
made. In contrast to primary Merkel cell carcinoma, 
there are no guidelines as to the treatment of 
pancreatic metastasis, which would account for the 
myriad of approaches undertaken in the above 
studies. It is noticeable that 50% were diagnosed 
post-resection but it is difficult to recommend this 
approach as the gold standard as survival and 
treatment data regarding those not resected were 
not reported. However, it would seem like a 
reasonable approach if the patient was fit enough 
and a R0 resection was possible. Nevertheless, this 
case report does prove that metastasis can be 
diagnosed by a biopsy and, as reported in several 
other cases, can be diagnosed by CK20 (epithelial) 
and CD56 (neuroendocrine) expression alone. 
CONCLUSION 
We report a rare case of a Merkel cell carcinoma 
metastasis to the pancreas and the rapidity of the 
patient’s deterioration justified our conservative 
management. It is important to exclude this rare 
cause of a mass in the pancreas in patients with a 
previous history of Merkel cell carcinoma, even if 
there is a long period between the primary tumour 
and the pancreatic mass. Whether this is done after 
resecting the mass, which is a reasonable approach 
if a R0 resections seems possible, or by biopsy/FNA 
remains to be determined. We believe the factors 
that should be taken into consideration include 
resectability of the lesion, disease spread and 
general fitness of the patient. 
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